Introduction:
Carbapenem-resistant Enterobacteriaceae (CRE) are recognized as an urgent threat to global human health due to their extensive antibiotic resistance and strong association with poor health outcomes. Here we undertook a genome-led investigation of carbapenem-resistant Enterobacter cloacae isolates from three hospitals to investigate suspected outbreaks.
Methods:
16 isolates from 3 hospitals (designated A, B, C) were collected between July-December 2015 and sequenced using the Illumina platform. Multi-locus sequence typing (MLST) and antibiotic resistance gene profiling was performed with srst2 using E. cloacae MLST profiles and the ARG-ANNOT database. Core genome single nucleotide polymorphisms (SNPs) were determined using Nesoni and the reference E. cloacae strain Ecl1.
Results:
All 10 Hospital-A isolates were found to be sequence type (ST) 90 and near-identical to Ecl1, altogether differing by 5 core SNPs. This suggests a persistent infectious source in the environment, as Ecl1 was originally isolated 2 years earlier from the same ward in Hospital-A. 3 of 4 isolates from Hospital-C and 1 of 2 from Hospital-B were also found to be very similar (ST65; within 58 core SNPs), but unrelated to the isolates from Hospital-A, indicative of a second outbreak involving two hospitals. All 16 isolates had very similar resistance gene profiles and 100% identical IMP carbapenemase genes.
Conclusions:
Genome sequencing enabled the detection of two discrete CRE outbreaks. Additionally, similar resistance gene profiles between E. cloacae of different STs suggest circulation of a novel plasmid/integron. Overall these results highlight the potential of genome sequencing in the clinical microbiology setting.